This page shows results related to Alaway and Urticaria from the FDA Adverse Event Reporting System (AERS). The adverse event Urticaria has been reported to the FDA a total of 4 times for Alaway.
Learn More About Alaway Adverse EventsThe Proportional Reporting Ratio (PRR) for Alaway and Urticaria is 2. The chart below compares this proportional reporting ratio of Urticaria for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Urticaria.
| Urticaria | |
| Alaway | 2 |
NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.
Of those reporting Urticaria, why were they taking Alaway?
| Histamine Abnormal | 1 |
| Seasonal Allergy | 1 |
| Eye Pruritus | 1 |
| Eye Swelling | 1 |
Which medications reported to the FDA are most commonly associated with Urticaria?
| Humira | 1415 |
| Remicade | 1205 |
| Enbrel | 1068 |
| Tysabri | 1056 |
| Magnevist | 1027 |
| Ultravist 300 | 810 |
| Avelox | 787 |
| Chantix | 557 |
| Fosamax | 531 |
| Niaspan | 434 |
| Xolair | 407 |
 Show More |
